More than half of patients prescribed semaglutide or liraglutide for all treatment durations studied were able to maintain or continue their weight loss one year after treatment
The universal conversion formula Every chart in this guide is built from one formula
Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear
The decrease in the size of thyroid nodules may result from supplementation with extracts of plants with antioxidant and anti-inflammatory properties (93)
It happens because GLP-1 receptor agonists like tirzepatide create sustained appetite suppression and delayed gastric emptying, leading to caloric deficits large enough to mobilise subcutaneous fat stores across the body, including the face
7 Strategies to Maximize Semaglutide's Impact on Emotional Eating While taking semaglutide reduces appetite and decreases emotion-driven hunger cues, the seven strategies below can fortify semaglutides impact on emotional eating